Abstract
Purpose
To investigate PTPRZ1 and CIN85 expression and their significance in cervical carcinoma.
Methods
The expression of PTPRZ1 and CIN85 was detected by immunohistochemistry and the association between PTPRZ1 and CIN85 expression and clinical pathological variables were analyzed.
Results
The expression of PTPRZ1 and CIN85 were significantly higher in cervical carcinoma than those in normal cervical epithelium. CIN85 expression was significantly higher in patients with deeper cervical invasion when compared with that with superficial invasion, while PTPRZ1 expression was significantly higher in patients with smaller tumor size (≤2 cm) than that with larger size (>2 cm). The expression of PTPRZ1 and CIN85 were higher in squamous cell carcinoma than those in adenocarcinoma.
Conclusions
There exist increased PTPRZ1 and CIN85 expression in cervical carcinoma and they are probably associated with tumor growth or invasion. PTPRZ1 and CIN85 expression were higher in squamous cell carcinoma than those in adenocarcinoma.
Similar content being viewed by others
References
Barnea G, Grumet M, Milev P, Silvennoinen O, Levy JB, Sap J et al (1994) Receptor tyrosine phosphatase β is expressed in the form of proteoglycan and binds to the extracellular matrix protein tenascin. J Biol Chem 269(20):14349–14352
Yamakawa T, Kurosawa N, Kadomatsu K, Matsui T, Itoh K, Maeda N (1999) Levels of expression of pleiotrophin and protein tyrosine phosphatase zeta are decreased in human colorectal cancers. Cancer Lett 135(1):91–96
Foehr ED, Lorente G, Kuo J, Ram R, Nikolich K, Urfer R (2006) Targeting of the receptor protein tyrosine phosphatase beta with a monoclonal antibody delays tumor growth in a glioblastoma model. Cancer Res 66(4):2271–2278
Wu CW, Kao HL, Li AF, Chi CW, Lin WC (2006) Protein tyrosine-phosphatase expression profiling in gastric cancer tissues. Cancer Lett 242(1):95–103
Goldmann T, Otto F, Vollmer E (2000) A receptor-type protein tyrosine phosphatase PTP zeta is expressed in human cutaneous melanomas. Folia Histochem Cytobiol 38(1):19–20
Ulbricht U, Brockmann MA, Aigner A, Eckerich C, Müller S, Fillbrandt R et al (2003) Expression and function of the receptor protein tyrosine phosphatase zeta and its ligand pleiotrophin in human astrocytomas. J Neuropathol Exp Neurol 62(12):1265–1275
Dikic I (2002) CIN85/CMS family of adaptor molecules. FEBS Lett 529(1):110–115 (review)
Dikic I, Giordano S (2003) Negative receptor signalling. Curr Opin Cell Biol 15(2):128–135 (review)
Szymkiewicz I, Kowanetz K, Soubeyran P, Dinarina A, Lipkowitz S, Dikic I (2002) CIN85 participates in Cbl-b-mediated down-regulation of receptor tyrosine kinases. J Biol Chem 277(42):39666–39672
Bögler O, Furnari FB, Kindler-Roehrborn A, Sykes VW, Yung R, Huang HJ et al (2000) SETA: a novel SH3 domain-containing adapter molecule associated with malignancy in astrocytes. Neuro Oncol 2(1):6–15
Mayevska O, Shuvayeva H, Igumentseva N, Havrylov S, Basaraba O, Bobak Y et al (2006) Expression of adaptor protein Ruk/CIN85 isoforms in cell lines of various tissue origins and human melanoma. Exp Oncol 28(4):275–281
Havrylov S, Rzhepetskyy Y, Malinowska A, Drobot L, Redowicz MJ (2009) Proteins recruited by SH3 domains of Ruk/CIN85 adaptor identified by LC–MS/MS. Proteome Sci 7(1):21
Petereit DG, Eifel PJ, Thomas GM (2007) Cervical cancer. In: Gunderson LL, Tepper JE (eds) Clinical radiation oncology, 2nd edn. Churchill Livingstone, Philadelphia, pp 1323–1357
Gadducci A, Teti G, Barsotti C, Tana R, Fanucchi A, Orlandini C et al (2010) Clinicopathological variables predictive of clinical outcome in patients with FIGO stage Ib2-IIb cervical cancer treated with cisplatin-based neoadjuvant chemotherapy followed by radical hysterectomy. Anticancer Res 30(1):201–208
Meng K, Rodriguez-Peña A, Dimitrov T, Chen W, Yamin M, Noda M et al (2000) Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proc Natl Acad Sci USA 97(6):2603–2608
Wu M, Gan K, Huang C, Tang Y, Chen Q, Tang K et al (2006) LRRC4 controls in vitro invasion of glioblastoma cells through inhibiting RPTP-zeta expression. J Neurooncol 80(2):133–142
Nagata S, Saito R, Yamada Y, Fujita N, Watanabe K (2001) Multiple variants of receptor-type protein tyrosine phosphatase beta are expressed in the central nervous system of Xenopus. Gene 262(1–2):81–88
Levy JB, Canoll PD, Silvennoinen O, Barnea G, Morse B, Honegger AM et al (1993) The cloning of a receptor-type protein tyrosine phosphatase expressed in the central nervous system. J Biol Chem 268(14):10573–10581
Lorente G, Nelson A, Mueller S, Kuo J, Urfer R, Nikolich K et al (2005) Functional comparison of long and short splice forms of RPTPbeta: implications for glioblastoma treatment. Neuro Oncol 7(2):154–163
Ulbricht U, Eckerich C, Fillbrandt R, Westphal M, Lamszus K (2006) RNA interference targeting protein tyrosine phosphatase zeta/receptor-type protein tyrosine phosphatase beta suppresses glioblastoma growth in vitro and in vivo. J Neurochem 98(5):1497–1506
Lu KV, Jong KA, Kim GY, Singh J, Dia EQ, Yoshimoto K et al (2005) Differential induction of glioblastoma migration and growth by two forms of pleiotrophin. J Biol Chem 280(29):26953–26964
Perez-Pinera P, Garcia-Suarez O, Menendez-Rodriguez P, Mortimer J, Chang Y, Astudillo A et al (2007) The receptor protein tyrosine phosphatase (RPTP)beta/zeta is expressed in different subtypes of human breast cancer. Biochem Biophys Res Commun 362(1):5–10
Nam JM, Onodera Y, Mazaki Y, Miyoshi H, Hashimoto S, Sabe H (2007) CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery. EMBO J 26(3):647–656
Gaidos G, Soni S, Oswald DJ, Toselli PA, Kirsch KH (2007) Structure and function analysis of the CMS/CIN85 protein family identifies actin-bundling properties and heterotypic–complex formation. J Cell Sci 120(14):2366–2377
Acknowledgments
This work was supported by the Scientific Research Foundation of Education Department of Zhejiang Province, China (Y200908905), Scientific Research Foundation of Ministry of Health, China (wkj2007-2-014) and the Nature Science Foundation of China (30872752).
Conflict of interest
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ma, Y., Ye, F., Xie, X. et al. Significance of PTPRZ1 and CIN85 expression in cervical carcinoma. Arch Gynecol Obstet 284, 699–704 (2011). https://doi.org/10.1007/s00404-010-1693-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1693-9